These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15342643)

  • 1. The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex.
    Young GD; Murphy-Ullrich JE
    J Biol Chem; 2004 Nov; 279(46):47633-42. PubMed ID: 15342643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular interactions that confer latency to transforming growth factor-beta.
    Young GD; Murphy-Ullrich JE
    J Biol Chem; 2004 Sep; 279(36):38032-9. PubMed ID: 15208302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.
    Schultz-Cherry S; Chen H; Mosher DF; Misenheimer TM; Krutzsch HC; Roberts DD; Murphy-Ullrich JE
    J Biol Chem; 1995 Mar; 270(13):7304-10. PubMed ID: 7706271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta.
    Ribeiro SM; Poczatek M; Schultz-Cherry S; Villain M; Murphy-Ullrich JE
    J Biol Chem; 1999 May; 274(19):13586-93. PubMed ID: 10224129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta.
    Saharinen J; Keski-Oja J
    Mol Biol Cell; 2000 Aug; 11(8):2691-704. PubMed ID: 10930463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
    Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB
    J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1.
    Guo NH; Krutzsch HC; Inman JK; Shannon CS; Roberts DD
    J Pept Res; 1997 Sep; 50(3):210-21. PubMed ID: 9309585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160.
    Olofsson A; Hellman U; Ten Dijke P; Grimsby S; Ichijo H; Morén A; Miyazono K; Heldin CH
    Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):427-34. PubMed ID: 9182700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
    Schultz-Cherry S; Lawler J; Murphy-Ullrich JE
    J Biol Chem; 1994 Oct; 269(43):26783-8. PubMed ID: 7929414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts.
    Atanasova VS; Russell RJ; Webster TG; Cao Q; Agarwal P; Lim YZ; Krishnan S; Fuentes I; Guttmann-Gruber C; McGrath JA; Salas-Alanis JC; Fertala A; South AP
    J Invest Dermatol; 2019 Jul; 139(7):1497-1505.e5. PubMed ID: 30684555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma.
    Lu A; Pallero MA; Lei W; Hong H; Yang Y; Suto MJ; Murphy-Ullrich JE
    Am J Pathol; 2016 Mar; 186(3):678-90. PubMed ID: 26801735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II.
    Belmadani S; Bernal J; Wei CC; Pallero MA; Dell'italia L; Murphy-Ullrich JE; Berecek KH
    Am J Pathol; 2007 Sep; 171(3):777-89. PubMed ID: 17640965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells.
    Wang S; Shiva S; Poczatek MH; Darley-Usmar V; Murphy-Ullrich JE
    J Biol Chem; 2002 Mar; 277(12):9880-8. PubMed ID: 11784717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-1 inhibits osteogenic differentiation of human mesenchymal stem cells through latent TGF-β activation.
    Bailey Dubose K; Zayzafoon M; Murphy-Ullrich JE
    Biochem Biophys Res Commun; 2012 Jun; 422(3):488-93. PubMed ID: 22583901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology.
    Murphy-Ullrich JE; Poczatek M
    Cytokine Growth Factor Rev; 2000; 11(1-2):59-69. PubMed ID: 10708953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions.
    Zhou Y; Poczatek MH; Berecek KH; Murphy-Ullrich JE
    Biochem Biophys Res Commun; 2006 Jan; 339(2):633-41. PubMed ID: 16310163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal integral membrane protein II binds thrombospondin-1. Structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif.
    Crombie R; Silverstein R
    J Biol Chem; 1998 Feb; 273(9):4855-63. PubMed ID: 9478926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo.
    Daniel C; Wiede J; Krutzsch HC; Ribeiro SM; Roberts DD; Murphy-Ullrich JE; Hugo C
    Kidney Int; 2004 Feb; 65(2):459-68. PubMed ID: 14717916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling.
    Sweetwyne MT; Pallero MA; Lu A; Van Duyn Graham L; Murphy-Ullrich JE
    Am J Pathol; 2010 Oct; 177(4):1710-24. PubMed ID: 20724603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented binding and activation of latent transforming growth factor-beta by a tryptic fragment of latency associated peptide.
    Abe M; Oda N; Sato Y; Shibata K; Yamasaki M
    Endothelium; 2002; 9(1):25-36. PubMed ID: 12901358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.